IDO Expression in Cancer: Different Compartment, Different Functionality?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IDO Expression in Cancer: Different Compartment, Different Functionality?
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-24
DOI
10.3389/fimmu.2020.531491
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
- (2020) Dayana Herrera-Rios et al. Frontiers in Immunology
- Up‐regulation of indoleamine 2,3‐dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients
- (2020) Qiang‐hua Zhou et al. Cancer Communications
- The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis
- (2020) Sen Wang et al. BMC CANCER
- Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer
- (2020) Ruochen Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Indoleamine 2,3-dioxygenase expression in the prognosis of the localized prostate cancer
- (2020) Janaina Mendes Ferreira et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder
- (2020) Donghyun Kim et al. Journal of Clinical Medicine
- Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
- (2020) Kristiina Karihtala et al. Cancers
- Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells
- (2020) Hannah Jonescheit et al. Cells
- Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
- (2020) Andrea Botticelli et al. Frontiers in Immunology
- Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression
- (2019) Haimeng Yan et al. CANCER LETTERS
- Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
- (2019) Geoffrey T. Gibney et al. Journal for ImmunoTherapy of Cancer
- High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes
- (2019) Tamkin Ahmadzada et al. LUNG CANCER
- The landscape of cancer cell line metabolism
- (2019) Haoxin Li et al. NATURE MEDICINE
- Indoleamine 2,3-Dioxygenase Activation by Interferon Gamma in Vascular Endothelial Rat Cells Requires Noncanonical NF-κB Signaling
- (2019) Yingzi Liang et al. TRANSPLANTATION PROCEEDINGS
- Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer
- (2019) Tiia J. Honkanen et al. Scientific Reports
- Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
- (2019) Karolina Okła et al. Frontiers in Immunology
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
- (2019) Kyohei Nakamura et al. Cellular & Molecular Immunology
- Metabolomic adaptations and correlates of survival to immune checkpoint blockade
- (2019) Haoxin Li et al. Nature Communications
- Assessment of peripheral endothelial function predicts future risk of solid-tumor cancer
- (2019) Takumi Toya et al. European Journal of Preventive Cardiology
- Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux?
- (2019) Clement Gascua Adu-Gyamfi et al. Frontiers in Cellular and Infection Microbiology
- Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
- (2019) Fotios Loupakis et al. Journal for ImmunoTherapy of Cancer
- Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer
- (2018) Fangxuan Li et al. CANCER BIOLOGY & THERAPY
- Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells
- (2018) Ailin Li et al. CANCER LETTERS
- High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma
- (2018) Andreas Seeber et al. CANCER SCIENCE
- Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma
- (2018) Pallavi A Patil et al. HISTOPATHOLOGY
- Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer
- (2018) Qian Ye et al. HUMAN PATHOLOGY
- Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization
- (2018) Fei Zhao et al. IMMUNITY
- Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma
- (2018) Nora Sundahl et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival
- (2018) Felicia Rubel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1
- (2018) Erik A. Dill et al. MODERN PATHOLOGY
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion
- (2018) Rohini L. Kadle et al. PLoS One
- Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
- (2018) Lieve Brochez et al. Nature Communications
- Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile
- (2018) Annabel Meireson et al. Oncotarget
- High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer
- (2018) Lijuan Wei et al. Frontiers in Immunology
- Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression
- (2018) Irina Banzola et al. Frontiers in Immunology
- Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
- (2018) A. Marijne Heeren et al. Frontiers in Immunology
- The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis
- (2018) Cheng-Peng Yu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
- (2018) Tara C. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
- (2018) Andrea Botticelli et al. Journal of Translational Medicine
- Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
- (2018) Alexander J. Muller et al. Seminars in Immunopathology
- Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer
- (2018) Eric Fox et al. Frontiers in Oncology
- Inter- and intra-patient heterogeneity of indoleamine 2,3-dioxygenase expression in primary and metastatic melanoma cells and the tumor microenvironment
- (2018) Tuba N. Gide et al. HISTOPATHOLOGY
- IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
- (2018) Ryan S. Lane et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications
- (2018) Martina Mandarano et al. VIRCHOWS ARCHIV
- The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
- (2017) Lieve Brochez et al. EUROPEAN JOURNAL OF CANCER
- Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer
- (2017) Kostandinos Sideras et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-Associated Fibroblasts and Microvessels Contribute to the Expression of Immunosuppressive Factor Indoleamine 2, 3-Dioxygenase in Human Esophageal Cancers
- (2017) Guanglin Cui et al. PATHOLOGY & ONCOLOGY RESEARCH
- A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes
- (2017) Hong Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
- (2017) Yuying Liu et al. Nature Communications
- Association of breast carcinoma growth with a non-canonical axis of IFNγ/IDO1/TSP1
- (2017) Bruno Lopes-Bastos et al. Oncotarget
- P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer
- (2017) Dongfang Tang et al. Oncotarget
- Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
- (2017) Marc Hennequart et al. Cancer Immunology Research
- Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells
- (2016) Tae Jin Yun et al. Cell Metabolism
- Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies
- (2016) A. M. Monjazeb et al. CLINICAL CANCER RESEARCH
- Pericyte–fibroblast transition promotes tumor growth and metastasis
- (2016) Kayoko Hosaka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma
- (2016) Atilla Engin et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Tumoral indoleamine 2, 3-dioxygenase 1 is regulated by monocytes and T lymphocytes collaboration in hepatocellular carcinoma
- (2016) Qiyi Zhao et al. Oncotarget
- Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment
- (2016) Cara C. Schafer et al. Oncotarget
- Tolerogenic IDO+ Dendritic Cells Are Induced by PD-1-Expressing Mast Cells
- (2016) Cecilia Pessoa Rodrigues et al. Frontiers in Immunology
- Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients
- (2015) Yunlong Jia et al. INTERNATIONAL JOURNAL OF CANCER
- The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
- (2015) Lijie Zhai et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
- (2015) Ines Chevolet et al. Journal of Translational Medicine
- High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia
- (2015) Ryoko Mabuchi et al. LEUKEMIA & LYMPHOMA
- Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients
- (2015) Ines Chevolet et al. MELANOMA RESEARCH
- Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction
- (2015) Sherin J. Rouhani et al. Nature Communications
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy
- (2015) A. Holtzhausen et al. Cancer Immunology Research
- Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival
- (2015) Debbie M Ferns et al. OncoImmunology
- Characterization of thein vivoimmune network of IDO, tryptophan metabolism, PD-L1, andCTLA-4in circulating immune cells in melanoma
- (2015) I Chevolet et al. OncoImmunology
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
- (2015) Valentina Folgiero et al. Oncotarget
- Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
- (2015) Ulrike M. Litzenburger et al. Oncotarget
- Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
- (2014) Ji-Young Choe et al. BMC CANCER
- Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
- (2014) I. Chevolet et al. BRITISH JOURNAL OF DERMATOLOGY
- Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
- (2014) Krishna S. Tummala et al. CANCER CELL
- The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: Focus on macrophage polarization of THP-1 cells
- (2014) Xian-Feng Wang et al. CELLULAR IMMUNOLOGY
- Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection
- (2014) Heng Zhang et al. Gastric Cancer
- Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment
- (2014) Sonia Moretti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation
- (2014) W. Chen et al. JOURNAL OF IMMUNOLOGY
- Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer
- (2014) Jinpu Yu et al. JOURNAL OF IMMUNOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- The Role of Placental Tryptophan Catabolism
- (2014) Peter Sedlmayr et al. Frontiers in Immunology
- Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
- (2014) Stefani Spranger et al. Journal for ImmunoTherapy of Cancer
- Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry
- (2013) Hatem Soliman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients
- (2013) Mercedes Herrera et al. CANCER SCIENCE
- IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells
- (2013) Terry-Ann Curran et al. IMMUNOBIOLOGY
- Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
- (2013) Brent A. Hanks et al. JOURNAL OF CLINICAL INVESTIGATION
- Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
- (2013) Rikke B. Holmgaard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
- (2013) J. Yu et al. JOURNAL OF IMMUNOLOGY
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer
- (2013) Chunyan Lan et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells
- (2012) E. F. Tewalt et al. BLOOD
- Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase
- (2012) Margit Lanzinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lymph node-derived lymphatic endothelial cells express functional costimulatory molecules and impair dendritic cell-induced allogenic T-cell proliferation
- (2012) Miriam Nörder et al. FASEB JOURNAL
- Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
- (2012) D Mougiakakos et al. LEUKEMIA
- The p53 network: cellular and systemic DNA damage responses in aging and cancer
- (2012) H. Christian Reinhardt et al. TRENDS IN GENETICS
- Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma
- (2012) Jin Ye et al. VIRCHOWS ARCHIV
- IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
- (2012) Courtney Smith et al. Cancer Discovery
- IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
- (2012) Richard Metz et al. OncoImmunology
- Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
- (2011) L Ferdinande et al. BRITISH JOURNAL OF CANCER
- Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
- (2011) Tuanjie Li et al. CANCER LETTERS
- Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
- (2011) Jonathan R. Brody et al. CELL CYCLE
- Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T CellsIn Situand Lymph Node Metastasis
- (2011) Jinpu Yu et al. Clinical & Developmental Immunology
- Involvement of Indoleamine 2,3-Dioxygenase in Impairing Tumor-Infiltrating CD8+T-Cell Functions in Esophageal Squamous Cell Carcinoma
- (2011) Ge Zhang et al. Clinical & Developmental Immunology
- High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma
- (2011) Jocelyne Jacquemier et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of IDO-Positive and IDO-Negative Human Dendritic Cells after Activation by Various Proinflammatory Stimuli
- (2011) D. Von Bubnoff et al. JOURNAL OF IMMUNOLOGY
- Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation
- (2011) Moïra François et al. MOLECULAR THERAPY
- An Observational Cohort Study of the Kynurenine to Tryptophan Ratio in Sepsis: Association with Impaired Immune and Microvascular Function
- (2011) Christabelle J. Darcy et al. PLoS One
- Vascular Endothelial Expression of Indoleamine 2,3-Dioxygenase 1 Forms a Positive Gradient towards the Feto-Maternal Interface
- (2011) Astrid Blaschitz et al. PLoS One
- Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy
- (2010) Tomoko Inaba et al. GYNECOLOGIC ONCOLOGY
- Kynurenine is an endothelium-derived relaxing factor produced during inflammation
- (2010) Yutang Wang et al. NATURE MEDICINE
- B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase
- (2010) B. A. Johnson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel role of plasmacytoid dendritic cells in humans: Induction of interleukin-10âproducing treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy
- (2009) Melina Kavousanaki et al. ARTHRITIS AND RHEUMATISM
- Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
- (2009) D. J. Chung et al. BLOOD
- Interferon- -triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells
- (2009) B. Jurgens et al. BLOOD
- Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis
- (2009) C Coquerelle et al. GUT
- Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells
- (2009) M. Brenk et al. JOURNAL OF IMMUNOLOGY
- IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
- (2009) B. Baban et al. JOURNAL OF IMMUNOLOGY
- Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer
- (2009) Yuzo Suzuki et al. LUNG CANCER
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression
- (2009) Erika L. Spaeth et al. PLoS One
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
- (2009) M. Balsamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression
- (2009) Guangwen Ren et al. STEM CELLS
- Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells
- (2009) Silvia Schmidt et al. THROMBOSIS AND HAEMOSTASIS
- Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas
- (2009) Jinzhong Liu et al. VIRCHOWS ARCHIV
- Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
- (2008) P. J. Mishra et al. CANCER RESEARCH
- Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival
- (2008) K. Ino et al. CLINICAL CANCER RESEARCH
- Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-γ
- (2008) Selim Corm et al. LEUKEMIA RESEARCH
- The role of VEGF-C staining in predicting regional metastasis in melanoma
- (2008) Barbara Boone et al. VIRCHOWS ARCHIV
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search